Invesco’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-237,134
Closed -$38.5K 3963
2023
Q4
$38.5K Buy
237,134
+65
+0% +$22 ﹤0.01% 3768
2023
Q3
$105K Buy
237,069
+2,021
+0.9% +$922 ﹤0.01% 3710
2023
Q2
$86.7K Sell
235,048
-16,708
-7% -$14.3K ﹤0.01% 3754
2023
Q1
$458K Buy
251,756
+180,746
+255% +$393K ﹤0.01% 3304
2022
Q4
$147K Buy
71,010
+54,891
+341% +$173K ﹤0.01% 3764
2022
Q3
$48K Sell
16,119
-14,195
-47% -$50.3K ﹤0.01% 3921
2022
Q2
$97K Buy
+30,314
New +$164K ﹤0.01% 3892

Other funds holding HLTH

Invesco's HLTH Position: Q1 2024 in Review

Invesco sold out of Cue Health Inc. Common Stock (HLTH) in Q1 2024, closing a stake of 237,134 shares — an estimated $38.5K sold.

Invesco first reported a position in HLTH in Q2 2022 and held it in 7 quarters. The position peaked at $458K in Q1 2023. 57 funds tracked by Wall St. Rank hold HLTH as of Q1 2024.

  • Invesco reported no remaining Cue Health Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Invesco sold 237,134 Cue Health Inc. Common Stock shares in Q1 2024, an estimated $38.5K.
  • Invesco first reported a position in Cue Health Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Invesco's Cue Health Inc. Common Stock position peaked at $458K in Q1 2023.
  • 57 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q1 2024.

Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.